These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
463 related items for PubMed ID: 23801416
1. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer. Kim SM, Kwon CH, Shin N, Park DY, Moon HJ, Kim GH, Jeon TY. Int J Cancer; 2014 Jan 01; 134(1):114-24. PubMed ID: 23801416 [Abstract] [Full Text] [Related]
2. Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression. Kang H, An HJ, Song JY, Kim TH, Heo JH, Ahn DH, Kim G. Histopathology; 2012 Oct 01; 61(4):576-86. PubMed ID: 22691042 [Abstract] [Full Text] [Related]
3. KITENIN is associated with tumor progression in human gastric cancer. Ryu HS, Park YL, Park SJ, Lee JH, Cho SB, Lee WS, Chung IJ, Kim KK, Lee KH, Kweon SS, Joo YE. Anticancer Res; 2010 Sep 01; 30(9):3479-86. PubMed ID: 20944126 [Abstract] [Full Text] [Related]
4. Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer. Kwon CH, Park HJ, Lee JR, Kim HK, Jeon TY, Jo HJ, Kim DH, Kim GH, Park DY. Br J Cancer; 2014 Nov 11; 111(10):1993-2002. PubMed ID: 25211665 [Abstract] [Full Text] [Related]
11. Prognostic value of Muc5AC in gastric cancer: A meta-analysis. Zhang CT, He KC, Pan F, Li Y, Wu J. World J Gastroenterol; 2015 Sep 28; 21(36):10453-60. PubMed ID: 26420972 [Abstract] [Full Text] [Related]
12. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer. Cheng HC, Liu YP, Shan YS, Huang CY, Lin FC, Lin LC, Lee L, Tsai CH, Hsiao M, Lu PJ. Carcinogenesis; 2013 Nov 28; 34(11):2452-9. PubMed ID: 23774402 [Abstract] [Full Text] [Related]
13. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y. Oncol Rep; 2012 Jan 28; 27(1):135-42. PubMed ID: 21947329 [Abstract] [Full Text] [Related]
14. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma. Fujimoto D, Goi T, Hirono Y. Int J Oncol; 2017 Feb 28; 50(2):448-456. PubMed ID: 28035352 [Abstract] [Full Text] [Related]
15. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T. J Clin Pathol; 2015 Oct 28; 68(10):795-801. PubMed ID: 26043748 [Abstract] [Full Text] [Related]
16. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas. Wang JY, Chang CT, Hsieh JS, Lee LW, Huang TJ, Chai CY, Lin SR. J Surg Oncol; 2003 Aug 28; 83(4):253-60. PubMed ID: 12884239 [Abstract] [Full Text] [Related]
17. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas. Zhao Y, Zhang T, Wang Q. Oncol Rep; 2013 Jul 28; 30(1):111-8. PubMed ID: 23612849 [Abstract] [Full Text] [Related]
18. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH. Ann Surg Oncol; 2009 Jan 28; 16(1):208-19. PubMed ID: 19009246 [Abstract] [Full Text] [Related]
19. Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. Shin NR, Jeong EH, Choi CI, Moon HJ, Kwon CH, Chu IS, Kim GH, Jeon TY, Kim DH, Lee JH, Park DY. BMC Cancer; 2012 Nov 14; 12():521. PubMed ID: 23151184 [Abstract] [Full Text] [Related]